Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies

Martijn W C Verbeek1, Stefan J Erkeland1, Vincent H J van der Velden1

  • 1Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.

Biomedicines
|June 24, 2022
PubMed

Insights

Small nucleolar RNAs (snoRNAs) are crucial for B-cell development and function. Dysregulated snoRNA expression is linked to various B-cell cancers, offering potential for new diagnostic and therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Immunology

Background:

  • Small nucleolar RNAs (snoRNAs) regulate RNA modifications, impacting mRNA splicing and protein translation.
  • Aberrant snoRNA expression is implicated in human cancer development and progression.
  • This review specifically examines snoRNAs in the context of normal and malignant B-cell development.

Purpose of the Study:

  • To review the role of snoRNAs in normal B-cell differentiation.
  • To explore the dysregulation of snoRNAs in various B-cell malignancies.
  • To discuss the potential of snoRNAs as diagnostic biomarkers or therapeutic targets in B-cell cancers.

Main Methods:

  • Literature review focusing on snoRNAs in B-cell development and malignancies.
  • Analysis of studies reporting snoRNA dysregulation in B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, B-cell non-Hodgkin's lymphoma, and plasma cell neoplasms.
  • Examination of the association between snoRNA expression, molecular subgroups, and clinical outcomes.

Main Results:

  • SnoRNA activity is essential for normal B-cell differentiation.
  • Dysregulated snoRNA expression is a hallmark of multiple B-cell malignancies.
  • SnoRNA expression patterns correlate with cytogenetic/molecular subgroups and patient prognosis.
  • Translocations involving snoRNAs have been identified in B-cell cancers.

Conclusions:

  • SnoRNAs play a critical role in both normal and malignant B-cell development.
  • Altered snoRNA expression contributes to oncogenic transformation in B-cell malignancies.
  • Targeting snoRNAs presents a promising avenue for novel diagnostic biomarkers and therapeutic interventions in B-cell cancers.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.6K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.7K